Cargando…
How to Choose the Optimal Starting Dose of Clomiphene Citrate (50 or 100 mg per Day) for a First Cycle of Ovulation Induction in Anovulatory PCOS Women?
Research question: Clomiphene citrate (CC) is one of the first-line treatments for ovulation induction in women with anovulatory polycystic ovary syndrome (PCOS). However, nearly 1 out of 2 women is resistant to 50 mg/day of CC. The objective of this study is to investigate the clinical, biological,...
Autores principales: | Huyghe, Lucie, Robin, Camille, Dumont, Agathe, Decanter, Christine, Kyheng, Maeva, Dewailly, Didier, Catteau-Jonard, Sophie, Robin, Geoffroy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10420149/ https://www.ncbi.nlm.nih.gov/pubmed/37568345 http://dx.doi.org/10.3390/jcm12154943 |
Ejemplares similares
-
Could Cytochrome P450 2D6, 3A4 and 3A5 Polymorphisms Explain the Variability in Clinical Response to Clomiphene Citrate of Anovulatory PCOS Women?
por: Robin, Camille, et al.
Publicado: (2021) -
The efficacy of metformin and clomiphene citrate combination compared with clomiphene citrate alone for ovulation induction in infertile patients with PCOS
por: Dasari, Papa, et al.
Publicado: (2009) -
Role of Anti-Müllerian Hormone in pathophysiology, diagnosis and treatment of Polycystic Ovary Syndrome: a review
por: Dumont, Agathe, et al.
Publicado: (2015) -
Predicting the FSH threshold dose in women with WHO Group II anovulatory infertility failing to ovulate or conceive on clomiphene citrate
por: Nyboe Andersen, Anders, et al.
Publicado: (2008) -
Altered Circulating Inflammatory Cytokines Are Associated with Anovulatory Polycystic Ovary Syndrome (PCOS) Women Resistant to Clomiphene Citrate Treatment
por: Wang, LianLian, et al.
Publicado: (2017)